Cardiac fibrosis

NG Frangogiannis - Cardiovascular research, 2021 - academic.oup.com
Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of
extracellular matrix proteins, is a common pathophysiologic companion of many different …

Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities

NG Frangogiannis - Molecular aspects of medicine, 2019 - Elsevier
Cardiac fibrosis is a common pathophysiologic companion of most myocardial diseases,
and is associated with systolic and diastolic dysfunction, arrhythmogenesis, and adverse …

How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association …

B Pieske, C Tschöpe, RA De Boer… - European heart …, 2019 - academic.oup.com
Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF)
remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA–PEFF …

The extracellular matrix in ischemic and nonischemic heart failure

NG Frangogiannis - Circulation research, 2019 - Am Heart Assoc
The ECM (extracellular matrix) network plays a crucial role in cardiac homeostasis, not only
by providing structural support, but also by facilitating force transmission, and by transducing …

Cardiac metabolism in HFpEF: from fuel to signalling

F Capone, C Sotomayor-Flores, D Bode… - Cardiovascular …, 2022 - academic.oup.com
Heart failure (HF) is marked by distinctive changes in myocardial uptake and utilization of
energy substrates. Among the different types of HF, HF with preserved ejection fraction …

Il-1 blockade in patients with heart failure with preserved ejection fraction: Results from dhart2

BW Van Tassell, CR Trankle, JM Canada… - Circulation: Heart …, 2018 - Am Heart Assoc
Background Enhanced inflammation may lead to exercise intolerance in heart failure with
preserved ejection fraction. The aim of the current study was to determine whether IL …

Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction

L Alex, I Russo, V Holoborodko… - American Journal of …, 2018 - journals.physiology.org
Heart failure with preserved ejection fraction (HFpEF) is caused, or exacerbated by, a wide
range of extracardiac conditions. Diabetes, obesity, and metabolic dysfunction are …

Galectin‐3 is a potential mediator for atherosclerosis

Z Gao, Z Liu, R Wang, Y Zheng, H Li… - Journal of immunology …, 2020 - Wiley Online Library
Atherosclerosis is a multifactorial chronic inflammatory arterial disease forming the
pathological basis of many cardiovascular diseases such as coronary heart disease, heart …

Heart failure with preserved ejection fraction diagnosis and treatment: an updated review of the evidence

MG Del Buono, G Iannaccone, R Scacciavillani… - Progress in …, 2020 - Elsevier
Over the last several decades, clinicians and clinical scientists have had growing interest in
heart failure (HF) diagnosis and treatment. While HF with reduced ejection fraction (EF) is a …

Missed diagnoses and health problems in adults with Prader-Willi syndrome: recommendations for screening and treatment

K Pellikaan, AGW Rosenberg… - The Journal of …, 2020 - academic.oup.com
Abstract Context Prader-Willi syndrome (PWS) is a complex hypothalamic disorder,
combining hyperphagia, hypotonia, intellectual disability, and pituitary hormone …